lemborexant 5 mg

1 INDICATIONS AND USAGE DAYVIGO is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance [see Clinical Studies ( 14.1 )] . DAYVIGO is an orexin receptor antagonist indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. ( 1 )

eisai inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] drug ineffective` `[4] off label use` `[5] pain` `[6] headache` `[7] diarrhoea` `[8] dyspnoea` `[9] arthralgia` `[10] vomiting`

2 years ago

ROUND YELLOW LEM 5

2 years ago

LEM 5 ROUND YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied DAYVIGO tablets are available as: 5 mg, pale yellow, round, biconvex, film-coated tablets, and debossed with "5" on one side and "LЄM" on the other side. NDC 62856-405-30, bottle of 30 with child-resistant closure NDC 62856-405-90, bottle of 90 with child-resistant closure 10 mg, orange, round, biconvex, film-coated tablets, and debossed with "10" on one side and "LЄM" on the other side. NDC 62856-410-30, bottle of 30 with child-resistant closure NDC 62856-410-90, bottle of 90 with child-resistant closure 16.2 Storage and Handling Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F) [See USP Controlled Room Temperature].

More pills like ROUND LEM 5

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

lemborexant 5 mg

FDA Reported Adverse Reactions [1] fatigue [2] nausea [3] drug ineffective [4] off label use [5] pain [6] headache [7] diarrhoea [8] dyspnoea [9] arthralgia [10] vomiting

ROUND YELLOW LEM 5

LEM 5 ROUND YELLOW

More pills like ROUND LEM 5

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] drug ineffective` `[4] off label use` `[5] pain` `[6] headache` `[7] diarrhoea` `[8] dyspnoea` `[9] arthralgia` `[10] vomiting`